https://ogma.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 Thyroid disease is a favorable prognostic factor in achieving sustained virologic response in chronic hepatitis C undergoing combination therapy: a nested case control study https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:15679 Wed 11 Apr 2018 17:12:34 AEST ]]> Thyroid disease in chronic hepatitis C Infection and interferon-α based therapy https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:13683 Wed 11 Apr 2018 13:31:00 AEST ]]> Development of thyroid diseases in the treatment of chronic hepatitis C with alpha-interferon may be a good prognosticator in achieving a sustained virological response: a meta-analysis https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:8319 Sat 24 Mar 2018 08:36:54 AEDT ]]> Pre-operative assessment of voice abnormalities in patients with thyroid disease: a clinical data-mining exploration of 'thyroid voice' https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:17677 Sat 24 Mar 2018 07:57:28 AEDT ]]> The adjuvant role of thyroxine in the treatment of chronic hepatitis C infection https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:25285 Sat 24 Mar 2018 07:38:12 AEDT ]]> Histopathologic findings of autoimmunity in thyroid, pituitary, and adrenal diseases in chronic hepatitis C postmortem cases https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:11187 Mon 08 Apr 2019 11:10:00 AEST ]]> Thyroid disease in chronic hepatitis C infection treated with combination interferon-α and ribavirin: management strategies and future perspective https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:19984 Mon 08 Apr 2019 11:09:34 AEST ]]>